Abstract
The Smith-Lemli-Opitz syndrome is a genetic disorder characterized by typical clinical features including reduced myelination of both brain and peripheral nervous system and defective cholesterol biosynthesis. In patients this results in very low cholesterol concentrations and accumulation of cholesterol precursors in plasma, tissues, cultured cells and faeces. We now show that the cholesterol concentration in CSF of Smith-Lemli-Opitz patients is markedly decreased and that 7- and 8-dehydrocholesterol concentrations are highly increased in comparison to controls. Moreover, dietary treatment of patients with cholesterol seems not to affect CSF cholesterol concentration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Alley TL, Gray BA, Lee S-H, et al (1995) Identification of a yeast artificial chromosome clone spanning a translocation breakpoint at 7q/32.1 in a Smith-Lemli-Opitz syndrome patient. Am J Hum Genet 56: 1411–1416.
Batta AK, Tint GS, Shefer S, Abuelo D, Salen G (1995) Identification of 8-dehydrocholesterol (cholesta-5,8-dien-3β-ol) in patients with Smith-Lemli-Opitz syndrome. J Lipid Res 36: 705–713.
Honda A, Tint GS, Salen G, Batta AK, Chen TS, Shefer S (1995) Defective conversion of 7-dehydrocholesterol to cholesterol in cultured skin fibroblasts from Smith-Lemli-Opitz syndrome homozygotes. J Lipid Res 36: 1595–1601.
Irons M, Elias ER, Salen G, Tint GS, Batta AK (1993) Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome. Lancet 341: 1414.
Kelley RI (1995) Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts. Clin Chim Acta 236: 45–58.
Mills K, Mandel H, Montemagno R, Soothil P, Gershoni-Baruch R, Clayton PT (1996) First trimester prenatal diagnosis of Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency). Pediatr Res 39: 816–819.
Smith DW, Lemli L, Opitz JM (1964) A newly recognized syndrome of multiple congenital anomalies. J Pediatr 64: 210–217.
Tint GS, Irons M, Elias ER, et al (1994) Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 330: 107–113.
Tint GS, Salen G, Batta AK, et al (1995) Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome. J Pediatr 127: 82–87.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Rooij, A., Nijenhuis, A.A., Wijburg, F.A. et al. Highly increased CSF concentrations of cholesterol precursors in Smith-Lemli-Opitz syndrome. J Inherit Metab Dis 20, 578–580 (1997). https://doi.org/10.1023/A:1005355026186
Issue Date:
DOI: https://doi.org/10.1023/A:1005355026186